Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Buy dildos.
Popular Articles

World Food Programme Calls For Urgent Action On Global Hunger And Humanitarian Needs
The Executive Director of the United Nations World Food Programme
pharmacy online
Wall Street Journal Examines Group Health Insurance Policies As Option For Uninsured
People who no longer have health insurance because of a job loss, voluntary retirement or other reasons have begun obtaining health coverage through the "little-known" option of group coverage, the Wall Street Journal reports. According to the Journal, the option is especially beneficial for people with pre-existing conditions to whom some insurers deny coverage. Federal law requires group policies to cover pre-existing conditions provided a person has not been uninsured for more than 63 days.To qualify for group coverage, an individual, a couple or a small group of people must provide evidence of ownership of an actual business, which could include freelance, contract or consulting work. Industry experts note that rules vary between states. In addition, group coverage could cost more than individual coverage, according to the Journal. The Journal reports that insurance companies might add extra fees for smaller groups. The smallest groups, sometimes of two or three people, can face surcharges of about 30% more than what larger groups pay, according to insurance broker Rick Martin.According to the Journal, it is unclear how many business owners currently are eligible for group coverage. Data from the Kaiser Family Foundation indicate that about one-third of the four million uninsured U.S. residents between ages 55 and 64 are self-employed, the Journal reports (Greene, Wall Street Journal, 5/27).
News of the day
FoldRx Pharmaceuticals Announces Positive Results From Pivotal Phase II/III Clinical Study Of Tafamidis
FoldRx Pharmaceuticals, Inc. (FoldRx) announced positive results from its pivotal Phase II/III clinical study of the company"s lead compound, tafamidis (Fx-1006A), in patients suffering from TTR amyloid polyneuropathy (ATTR-PN), a fatal orphan disease also known as Familial Amyloid Polyneuropathy (FAP). Liver transplantation is the only currently available treatment option for this progressive neurodegenerative disease. Preliminary results from the first randomized controlled trial ever completed in this disease demonstrate that tafamidis treatment significantly halts disease progression in ATTR-PN, reduces the burden of disease after 18 months compared to placebo, and appears to be safe and well-tolerated.
Sexual Health

Sleep Deprivation: A Health Hazard Yet To Be Taken Seriously

A new survey released by Royal Philips Electronics (AEX: PHI, NYSE: PHG) shows that the average manager is sleeping 19 percent less than the recommended amount of eight hours a night. The survey, conducted in five countries around the globe, showed that 40 percent of those questioned blame the state of the world economy as the major reason for their lack of sleep. A vast majority of respondents to the survey (61 percent) say they have had their work impacted negatively by lack of sleep. On average, each estimated 6.2 days per year were impacted by inadequate sleep - costing companies around the globe millions. In the UK for example, 6.7 days per year are impacted by lack of sleep and companies are losing nearly ÷£850 of productivity per manager per year. With 4.3m managers in the UK (1), the cost to the economy could be as high as ÷£3.63bn a year. "People lose sleep either because they cannot sleep (insomnia) or because they are not setting aside enough time for sleep - both of which can happen because of work-related stress in the current economic environment," said Dr. David White, chief medical officer for Philips Home Healthcare Solutions. "People simply need to take sleep much more seriously." "Sleep is not optional - it is absolutely critical to people"s health," continued Dr. White "The consequences of not sleeping enough are well documented. People who do not get enough sleep can gain weight, are prone to diabetes, high blood pressure and even heart attacks. We are facing a serious healthcare problem if we do not take sleep more seriously." In addition to the findings about lack of sleep, the survey also found that while 96 percent of managers recognize that inadequate sleep can seriously affect a person"s health, only 29 percent discuss their problematic sleep patterns. Of those that do, just 27 percent seek professional help from a physician with the majority simply talking about their problems with family and friends. Respondents were also polled on their awareness of a relatively common sleep disorder, Obstructive Sleep Apnea (OSA), a condition characterized by the repeated cessation of breathing during sleep. The occurrence of OSA amongst young adults is relatively high. It is estimated that in the UK, for example, over 770,000 people suffer from moderate to severe OSA, with only a fraction being diagnosed. Other findings from the survey included a very high awareness of Obstructive Sleep Apnea (OSA) as a curable illness (60 percent). Interestingly, despite the fact that snoring can be a key symptom of OSA, only 35 percent considered snoring a problem for them personally and 65 percent described snoring as a minor inconvenience that they did not feel needed to be dealt with. This highlights a key problem facing the medical profession which is that Sleep apnea and other sleep disorders are often under diagnosed because people do not recognize the symptoms or do not take sleep problems seriously enough to talk to their physicians. Research in recent years has shown a link between OSA, heart disease, stroke and diabetes. This survey commissioned by Philips was undertaken by TNS during March 2009. It surveyed 2,500 managers*- equally split across the UK, Germany, USA, Japan and The Netherlands - using an online poll. Philips mandated the survey to obtain an indication of peoples" sleep habits and their awareness of the impact of sleep on health and quality of life. As a leader in the sleep management market and the treatment of Obstructive Sleep Apnea, Philips" sleep therapy products are designed to encourage patients" acceptance of OSA therapy through increased comfort. The end result is improved sleep and, ultimately, improved quality of life. Notes Survey demographics - 2513 people were interviewed of which 59% (1483) were male and 41% (1030) were female - The split in age groups was as follows: under 25 - 7%; 26 to 35 - 20%; 36 to 45 - 25%; 46 to 55 - 26%; 56 to 65 - 18%; over 65 - 4% - The research was conducted in UK (501), USA (502), Netherlands (501), Germany (500) and Japan (509) *Only those with managerial responsibility were asked for their views: company owner / founder (31%); partner (5%); Board Director (4%); senior management (13%); middle manager/department manager (31%); and junior manager / supervisor / team leader (16%) (1) Office of National Statistics in the UK Royal Philips Electronics


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009